2015 - Member of the National Academy of Medicine (NAM)
Fellow of the Royal Society of South Africa
His scientific interests lie mostly in Streptococcus pneumoniae, Immunology, Pneumococcal infections, Microbiology and Pneumococcal conjugate vaccine. His research integrates issues of Serotype, Virology, Antibiotic resistance and Pneumonia in his study of Streptococcus pneumoniae. His Immunology research is multidisciplinary, incorporating perspectives in Internal medicine, Epidemiology and Respiratory tract infections.
His work deals with themes such as Carriage, Molecular epidemiology, Azithromycin and Colonization, which intersect with Pneumococcal infections. The various areas that he examines in his Microbiology study include Human pathogen, Nucleic acid sequence, Gene and Virulence. His Pneumococcal conjugate vaccine research includes elements of Pneumococcal vaccine, Haemophilus influenzae and Vaccine efficacy.
Keith P. Klugman focuses on Streptococcus pneumoniae, Microbiology, Immunology, Virology and Serotype. The Streptococcus pneumoniae study combines topics in areas such as Penicillin, Antibiotic resistance and Pneumonia. He focuses mostly in the field of Pneumonia, narrowing it down to topics relating to Intensive care medicine and, in certain cases, Disease.
Keith P. Klugman interconnects Meningitis, Internal medicine, Respiratory tract infections and Acquired immunodeficiency syndrome in the investigation of issues within Immunology. The concepts of his Virology study are interwoven with issues in Neisseria meningitidis, Multilocus sequence typing, Genotype and Conjugate vaccine. Keith P. Klugman combines subjects such as Carriage, Quellung reaction and Molecular epidemiology with his study of Serotype.
His main research concerns Serotype, Streptococcus pneumoniae, Virology, Pneumococcal conjugate vaccine and Immunology. His studies deal with areas such as Bioinformatics, Pneumonia, Antibiotic resistance, Pneumococcal pneumonia and Virulence as well as Serotype. His Streptococcus pneumoniae research is under the purview of Microbiology.
His Virology study combines topics from a wide range of disciplines, such as Conjugate vaccine, Drug resistance and Genotype. His Pneumococcal conjugate vaccine research is multidisciplinary, incorporating elements of Coinfection, Pneumococcal vaccine, Epidemiology and Pneumococcal disease. His research in Immunology intersects with topics in Asymptomatic and Typhoid fever.
His primary areas of study are Serotype, Vaccination, Virology, Streptococcus pneumoniae and Pneumococcal conjugate vaccine. In his research, Disease is intimately related to Antibiotic resistance, which falls under the overarching field of Serotype. The study incorporates disciplines such as Antigenicity, Drug resistance, Conjugate vaccine and Population study in addition to Virology.
His Streptococcus pneumoniae study results in a more complete grasp of Microbiology. His Pneumococcal conjugate vaccine research incorporates elements of Pediatrics and Pneumococcal disease. His Immunology research includes themes of Transmission, Lower risk and Asymptomatic.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.
Keith P. Klugman;Keith P. Klugman;Shabir A. Madhi;Robin E. Huebner;Robert Kohberger.
The New England Journal of Medicine (2003)
Pneumococcal resistance to antibiotics.
K P Klugman.
Clinical Microbiology Reviews (1990)
Antimicrobial resistance in developing countries. Part I: recent trends and current status
Iruka N Okeke;Ramanan Laxminarayan;Zulfiqar A Bhutta;Adriano G Duse.
Lancet Infectious Diseases (2005)
Management of Community-Acquired Pneumonia in the Era of Pneumococcal Resistance: A Report From the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group
James D. Heffelfinger;Scott F. Dowell;James H. Jorgensen;Keith P. Klugman.
JAMA Internal Medicine (2000)
Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis
Harish Nair;Harish Nair;W Abdullah Brooks;Mark Katz;Anna Roca.
The Lancet (2011)
Rapid Pneumococcal Evolution in Response to Clinical Interventions
Nicholas J. Croucher;Simon R. Harris;Christophe Fraser;Michael A. Quail.
Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum β-Lactamases: Implications for the Clinical Microbiology Laboratory
David L. Paterson;David L. Paterson;Wen-Chien Ko;Anne Von Gottberg;Jose Maria Casellas.
Journal of Clinical Microbiology (2001)
Epidemiological differences among pneumococcal serotypes
William P Hausdorff;Daniel R Feikin;Keith P Klugman.
Lancet Infectious Diseases (2005)
Access to effective antimicrobials: a worldwide challenge.
Ramanan Laxminarayan;Ramanan Laxminarayan;Precious Matsoso;Suraj Pant;Charles Brower.
The Lancet (2016)
Antibiotic Therapy for Klebsiella pneumoniae Bacteremia: Implications of Production of Extended-Spectrum β-Lactamases
David L. Paterson;David L. Paterson;Wen Chien Ko;Anne Von Gottberg;Sunita Mohapatra.
Clinical Infectious Diseases (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: